You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,474,783


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,474,783
Title: Solubility parameter based drug delivery system and method for altering drug saturation concentration
Abstract:The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.
Inventor(s): Miranda; Jesus (Miami, FL), Sablotsky; Steven (Miami, FL)
Assignee: Noven Pharmaceuticals, Inc. (Miami, FL)
Application Number:07/722,342
Patent Claim Types:
see list of patent claims
Delivery; Composition;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 5,474,783

Introduction

United States Patent 5,474,783, titled "Solubility parameter based drug delivery system and method for altering drug saturation concentration," is a significant patent in the field of pharmaceuticals and drug delivery systems. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Number and Authority

The patent, US5474783A, was issued by the United States Patent and Trademark Office (USPTO) and is now expired due to the completion of its lifetime[4].

Inventors and Assignees

While the specific inventors and assignees are not detailed here, it is crucial to identify them in a comprehensive analysis to understand the ownership and potential licensing or assignment history of the patent.

Prior Art and Background

The patent builds on prior art related to drug delivery systems, particularly those involving transdermal drug delivery. The background section of the patent discusses the limitations of existing drug delivery methods and the need for a more efficient and controlled release system.

Scope of the Invention

Drug Delivery System

The invention describes a drug delivery system based on solubility parameters. This system aims to alter the drug saturation concentration, enhancing the efficacy and stability of the drug delivery process. The system involves the use of specific polymers and solvents that optimize the solubility of the drug, ensuring a consistent and controlled release[4].

Key Components

  • Polymers: The patent specifies the use of polymers such as polysiloxane and polyacrylate, which are crucial for the drug delivery matrix.
  • Solvents: The invention includes the use of solvents like methyl oleate and isopropyl myristate to enhance the solubility of the drug.
  • Drug Types: The system is designed to deliver a variety of drugs, including nitroglycerin, salbutamol, pilocarpine, and others[4].

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically describe the drug delivery system, the method of preparing it, and the specific components used.

  • Claim 1: This claim describes the drug delivery system comprising a polymer matrix and a solvent, with the drug dispersed within the matrix.
  • Claim 2: This claim outlines the method of preparing the drug delivery system, including the steps of mixing the drug with the polymer and solvent.

Dependent Claims

Dependent claims further specify the details of the independent claims, such as the types of polymers and solvents used, the concentration of the drug, and the method of application (e.g., transdermal delivery)[4].

Patent Landscape Analysis

Defining Scope and Keywords

To analyze the patent landscape surrounding US5474783A, one must first define the scope and relevant keywords. Keywords might include "drug delivery system," "solubility parameter," "transdermal drug delivery," and specific polymers and solvents mentioned in the patent[5].

Searching and Organizing Patents

Using databases such as the USPTO's Patent Public Search, Google Patents, or the European Patent Office's esp@cenet, one can search for patents related to these keywords. Organizing these patents by factors like filing date, assignee, and technology subcategories helps in identifying trends and key players[1][5].

Identifying Trends and Key Players

The analysis reveals trends in patent filings within the drug delivery technology domain. Key players in this field include pharmaceutical companies and research institutions that have filed numerous patents related to drug delivery systems. For example, companies like Johnson & Johnson, Pfizer, and Novartis are often significant contributors in this area.

Analyzing Citations and Evolution

Studying how patents reference each other provides insights into the impact and development of the technology. The Common Citation Document (CCD) application can be useful here, as it consolidates prior art cited by multiple patent offices for the same invention[1].

Data Visualization and Analysis

Creating visualizations such as heat maps and citation networks helps in revealing geographical distribution, interconnections among patents, and areas of high patent activity. This can identify emerging technologies and potential white spaces in the market[5].

Insights from Patent Landscape Analysis

Technological Trends

The analysis shows ongoing innovations in drug delivery systems, with a focus on improving efficacy, stability, and patient compliance. Trends include the use of advanced polymers, nanotechnology, and personalized medicine approaches.

Competitive Landscape

Understanding the competitive landscape helps in identifying potential competitors and collaborators. For instance, a company may find that a particular technology is heavily patented by a competitor, indicating a need to either license the technology or develop an alternative.

Legal Vulnerabilities

Analyzing the patent landscape also reveals potential legal vulnerabilities. For example, if a company's patent portfolio is weak in a particular area, it may be more susceptible to patent infringement claims from competitors.

Key Takeaways

  • Invention Scope: The patent describes a solubility parameter-based drug delivery system, enhancing drug saturation concentration.
  • Claims: The patent includes independent and dependent claims specifying the system, method of preparation, and components.
  • Patent Landscape: The analysis reveals trends, key players, and technological evolution in the drug delivery field.
  • Insights: The analysis provides actionable insights for strategic decisions, competitive positioning, and legal considerations.

FAQs

What is the main innovation of US Patent 5,474,783?

The main innovation is a drug delivery system based on solubility parameters to enhance the efficacy and stability of drug delivery.

What types of polymers are used in this patent?

The patent specifies the use of polymers such as polysiloxane and polyacrylate.

How does the patent landscape analysis help in understanding this patent?

It helps in identifying trends, key players, and technological evolution in the drug delivery field, providing insights for strategic decisions and competitive positioning.

What databases can be used for searching related patents?

Databases such as the USPTO's Patent Public Search, Google Patents, and the European Patent Office's esp@cenet can be used.

What is the significance of the Common Citation Document (CCD) in patent landscape analysis?

The CCD consolidates prior art cited by multiple patent offices for the same invention, enabling a comprehensive view of the patent's impact and development.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,474,783

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.